A multicomponent behavioural and drug intervention for nocturia in elderly men: Rationale and pilot results

BJU International

Volumn 104, Issue 1, 2009, Pages 69-74

  Vaughan, Camille P ^a,b,c   Endeshaw, Yohannes ^c   Nagamia, Zobair ^b   Ouslander, Joseph G ^d   Johnson, Theodore M ^b,c  

^a ATLANTA VA MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

^d FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

Aged; Behavioural therapy; Drug therapy; Multicomponent therapy; Nocturia

Indexed keywords

DIURETIC AGENT; TERAZOSIN; TOLTERODINE; ZALEPLON;

AGED; AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX; AROUSAL; ARTICLE; BEHAVIOR THERAPY; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL PROTOCOL; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE SEVERITY; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFECT; DRUG TOLERABILITY; EVENING DOSAGE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NOCTURIA; OPEN STUDY; ORTHOSTATIC HYPERTENSION; OUTCOME ASSESSMENT; PILOT STUDY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE HYPERTROPHY; RISK FACTOR; SELF REPORT; SLEEP; TREATMENT RESPONSE; URINARY FREQUENCY;

ACETAMIDES; ADRENERGIC ALPHA-ANTAGONISTS; AGED; BEHAVIOR THERAPY; BENZHYDRYL COMPOUNDS; COMBINED MODALITY THERAPY; CRESOLS; EPIDEMIOLOGIC METHODS; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; NOCTURIA; PHENYLPROPANOLAMINE; PRAZOSIN; PROSTATIC HYPERPLASIA; PYRIMIDINES; TREATMENT OUTCOME; URINARY BLADDER, OVERACTIVE;

EID: 67650506780     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08353.x     Document Type: Article

References (29)

1. Van Kerrebroeck P, Abrams P, Chaikin D et al. The standardization of terminology in nocturia: report from the standardization subcommittee of the International Continence Society. BJU Int 2002 90 (Suppl. 3 11 5
2. Tikkinen KA, Tammela TL, Huhtala H, Auvinen A. Is nocturia equally common among men and women? A population based study in Finland. J Urol 2006 175 : 596 600 (Pubitemid 43067379)
3. DuBeau CE, Yalla SV, Resnick NM. Implications of the most bothersome prostatism symptom for clinical care and outcomes research. J Am Geriatr Soc 1995 43 : 985 92
4. Samuelsson E, Victor A, Tibblin G. A population study of urinary incontinence and nocturia among women aged 20-59 years. Prevalence, well-being and wish for treatment. Acta Obstet Gynecol Scand 1997 76 : 74 80
5. Asplund R, Aberg H. Health of the elderly with regard to sleep and nocturnal micturition. Scand J Prim Health Care 1992 10 : 98 104
6. Asplund R, Aberg HE. Micturition habits of older people. Voiding frequency and urine volumes. Scand J Urol Nephrol 1992 26 : 345 9
7. Foley DJ, Vitiello MV, Bliwise DL, Ancoli-Israel S, Monjan AA, Walsh JK. Frequent napping is associated with excessive daytime sleepiness, depression, pain, and nocturia in older adults: findings from the National Sleep Foundation '2003 Sleep in America' Poll. Am J Geriatr Psychiatry 2007 15 : 344 50
8. Parsons M, Tissot W, Cardozo L et al. Normative bladder diary measurements: night versus day. Neurourol Urodyn 2007 26 : 465 73
9. Weatherall M, Arnold T. New Zealand Nocturia Guideline C. Nocturia in adults: draft New Zealand guidelines for its assessment and management in primary care. N Z Med J 2006 119 : U1976
10. Johnson TM II, Sattin RW, Parmelee P, Fultz NH, Ouslander JG. Evaluating potentially modifiable risk factors for prevalent and incident nocturia in older adults. J Am Geriatr Soc 2005 53 : 1011 6
11. Fitzgerald MP, Litman HJ, Link CL, McKinlay JB. The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey. J Urol 2007 177 : 1385 9
12. Coyne KS, Zhou Z, Bhattacharyya SK, Thompson CL, Dhawan R, Versi E. The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA. BJU Int 2003 92 : 948 54
13. Cardozo L, Lisec M, Millard R et al. Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder. J Urol 2004 172 : 1919 24
14. Johnson TM II, Burgio KL, Redden DT, Wright KC, Goode PS. Effects of behavioral and drug therapy on nocturia in older incontinent women. J Am Geriatr Soc 2005 53 : 846 50
15. Johnson TM II, Jones K, Williford WO, Kutner MH, Issa MM, Lepor H. Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial. J Urol 2003 170 : 145 8
16. Drake MJ, Mills IW, Noble JG. Melatonin pharmacotherapy for nocturia in men with benign prostatic enlargement. J Urol 2004 171 : 1199 202
17. Kaplan SA, Roehrborn CG, Rovner ES, Carlsson M, Bavendam T, Guan Z. Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. JAMA 2006 296 : 2319 28
18. Athanasopoulos A, Gyftopoulos K, Giannitsas K, Fisfis J, Perimenis P, Barbalias G. Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study. J Urol 2003 169 : 2253 6
19. Lose G, Lalos O, Freeman RM, van Kerrebroeck P, Nocturia Study G. Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women. Am J Obstet Gynecol 2003 189 : 1106 13
20. Mattiasson A, Abrams P, Van Kerrebroeck P, Walter S, Weiss J. Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men. BJU Int 2002 89 : 855 62
21. Sagnier PP, MacFarlane G, Teillac P, Botto H, Richard F, Boyle P. Impact of symptoms of prostatism on level of bother and quality of life of men in the French community. J Urol 1995 153 : 669 73
22. Yoshimura K, Kamoto T, Oka Y et al. Differences between bothersome and non-bothersome night-time frequency. Neurourol Urodyn 2007 26 : 1014 9
23. Johnson TM, Ouslander JG, Uman GC, Schnelle JF. Urinary incontinence treatment preferences in long-term care. J Am Geriatr Soc 2001 49 : 710 8
24. Tinetti ME, Baker DI, McAvay G et al. A multifactorial intervention to reduce the risk of falling among elderly people living in the community. N Engl J Med 1994 331 : 821 7
25. Inouye SK, Bogardus ST Charpentier PA et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999 340 : 669 76
26. DuBeau CE, Yalla SV, Resnick NM. Improving the utility of urine flow rate to exclude outlet obstruction in men with voiding symptoms. J Am Geriatr Soc 1998 46 : 1118 24
27. Rembratt A, Riis A, Norgaard JP. Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia. Neurourol Urodyn 2006 25 : 105 9
28. Johnson TM, Burridge A, Issa MM, Miller M, Tang T, Ouslander JG. The relationship between the action of arginine vasopressin and responsiveness to oral desmopressin in older men: a pilot study. J Am Geriatr Soc 2007 55 : 562 9
29. Allore HG, Tinetti ME, Gill TM, Peduzzi PN. Experimental designs for multicomponent interventions among persons with multifactorial geriatric syndromes. Clin Trials 2005 2 : 13 21 (Pubitemid 40332924)